Skip to content

Latest Post

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss Manipur Liquor Tragedy: Toll Hits 15 as 300+ Treated for Suspected Methanol Poisoning
  • Sun. Nov 22nd, 2026
MedGadget.in logo – medical technology news and healthcare technology insights

  • Home
  • About Us
  • Author
  • Contact Us
Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb

The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…

Clinical Trials

India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial

November 21, 2026 Simone Lamb

A CDSCO expert panel recommended a Phase I trial of Indian Immunologicals' live attenuated Zika vaccine, developed with Griffith University and funded by ICMR.

Clinical Trials

Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients

November 21, 2026 Simone Lamb

PMV Pharmaceuticals' rezatapopt produced a 48% response rate in platinum-resistant ovarian cancer with TP53 Y220C in the pivotal PYNNACLE trial, with an FDA filing planned…

Clinical Trials

GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss

November 21, 2026 Simone Lamb

Mayo Clinic data from ObesityWeek 2026 show GLP-1 users with weakened hearts saw greater one-year gains in heart structure and function than matched non-users, with…

Healthcare Services

Manipur Liquor Tragedy: Toll Hits 15 as 300+ Treated for Suspected Methanol Poisoning

November 21, 2026 Simone Lamb

Up to 15 people have died and more than 300 have sought care in Imphal after drinking spurious liquor in Manipur's Chandel district. What we…

Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb

The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn…

Pharmaceutical

Infigratinib Gets FDA Priority Review for Achondroplasia

October 7, 2026 Simone Lamb

FDA accepts the oral infigratinib NDA for achondroplasia with Priority Review and a 4 February 2027 goal date. See the PROPEL 3 data and what happens next.

Pharmaceutical

EPCORE DLBCL-2: Epcoritamab Plus R-CHOP Cuts Risk 51%

October 6, 2026 Simone Lamb

Epcoritamab plus R-CHOP met the primary PFS endpoint in the Phase 3 EPCORE DLBCL-2 trial, cutting progression risk 51%. What it means for DLBCL.

Pharmaceutical

Lilly Expands Gate Bioscience Deal to Over $870 Million

October 6, 2026 Simone Lamb

Lilly adds a target to its Gate Bioscience molecular gates collaboration, with total potential value above $870M. What is and is not disclosed.

Pharmaceutical

CSL Alentis Partnership: $1.6B Lixudebart Deal Explained

October 6, 2026 Simone Lamb

CSL pays $355M upfront in a partnership with Alentis to co-develop lixudebart for rare kidney and liver diseases, worth up to about $1.6B.

Medical Device

HeartBeam Wins FDA Breakthrough Status for Heart Attack Tool

October 6, 2026 Simone Lamb

FDA granted HeartBeam Breakthrough Device Designation for its 3D ECG system to help physicians assess suspected heart attacks, including at home.

Medical Device

AIRS Medical SwiftSight Body Composition Cleared by FDA

October 6, 2026 Simone Lamb

FDA has cleared AIRS Medical’s SwiftSight Body Composition, AI software that measures fat, muscle and liver fat from an MRI scan of under five minutes.

Medical Device

Axogen Completes $200 Million BioCircuit Acquisition

October 5, 2026 Simone Lamb

Axogen closed its $200 million cash purchase of BioCircuit on 1 October, adding NerveTape, an FDA-cleared sutureless nerve repair device, to its portfolio.

Pharmaceutical

Velsipity Local Manufacturing in China Gets Priority Review

October 5, 2026 Simone Lamb

Everest Medicines’ application to make Velsipity locally in China won priority review; production is anticipated in 2027 at about 50 million tablets a year.

Healthcare Services

Health Insurers Weigh 10% Co-Pay on Hospital Bills in 2027

October 5, 2026 Simone Lamb

Indian insurers are weighing a 10% co-pay on hospital claims, capped at Rs 5 lakh, from 1 January 2027 in exchange for lower premiums. What it means.

Pharmaceutical

Kusum Sumy Plant May Stay Shut 1-2 Years After Drone Strike

October 5, 2026 Simone Lamb

Six drones hit Kusum Healthcare's Sumy plant in Ukraine, killing an engineer; co-founder Sanjeev Gupta says it could stay shut for one to two years.

Posts pagination

1 … 29 30 31 … 36

You missed

Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb
Clinical Trials

India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial

November 21, 2026 Simone Lamb
Clinical Trials

Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients

November 21, 2026 Simone Lamb
Clinical Trials

GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss

November 21, 2026 Simone Lamb
MedGadget.in logo – medical technology news and healthcare technology insights

Proudly powered by WordPress | Theme: NewsTwenty by Themeansar.

  • Home
  • About Us
  • Author
  • Contact Us